Company Profile
live
SmallGlox Therapeutics Limited
sc760230•Private Limited With Share Capital
John Arbuthnott Building, Strathclyde University Of Pharma, Glasgow, G40RE
Get Full Access
Incorporated
27/02/2023
Company Age
3 years
Directors
3
Employees
3
SIC Code
72110
Risk
low risk
Company Overview
Registration, classification & business activity
Glox Therapeutics Limited (sc760230) is a private limited with share capital incorporated on 27/02/2023 (3 years old) and registered in glasgow, G40RE. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Glox therapeutics ltd. is developing novel precision antibiotics based on protein bacteriocins, which have potent narrow-spectrum activity to target gram-negative antimicrobial resistant (amr) pathogens.
Private Limited With Share Capital
SIC: 72110
Small
Incorporated 27/02/2023
G40RE
3 employees
Financial Overview
Total Assets
£798.0K
Liabilities
£369.5K
Net Assets
£428.5K
Est. Turnover
£520.0K
AI Estimated
Unreported
Cash
£634.2K
Key Metrics
3
Employees
3
Directors
8
Shareholders
Board of Directors
3
Name
Position
Import / Export
Imports
12 Months4
60 Months4
Exports
12 Months0
60 Months0
Risk Assessment
low risk
International Score
Future Factor
good
Performance Rating
Accounts
Typetotal exemption full
Due Date30/09/2027
Filing Date30/09/2026
Latest Accounts31/12/2025
Trading Addresses
Central Mail Room, University Avenue, Glasgow, G128QQRegistered
John Arbuthnott Building, 161 Cathedral Street, Glasgow, G40RERegistered
11 University Avenue The Square, Glasgow, Lanarkshire, G128QQ
John Arbuthnott Building, 161 Cathedral Street, Glasgow, G40RERegistered
Related Companies
2
Contact
John Arbuthnott Building, Strathclyde University Of Pharma, Glasgow, G40RE